Skip to main content
. 2020 Aug 1;4(10):1502–1515. doi: 10.1002/hep4.1567

TABLE 5.

Number of Times a PRO Concept Is Mentioned in Unpublished and Ongoing Studies Listed in US and EU Clinical Trials Registries for PBC and PSC

PRO Concepts Frequency, n (%)
PBC (n = 50) PSC (n = 34) Total (n = 88)
Functioning/quality of life
Broad HRQOL 14 (28.0) 9 (26.5) 24 (27.3)
Cognitive functioning 1 (2.0) 0 (0.0) 1 (1.1)
Physical functioning 1 (2.0) 1 (2.9) 2 (2.3)
Symptoms
Anxiety 1 (2.0) 0 (0.0) 1 (1.1)
Autonomic dysfunction 1 (2.0) 0 (0.0) 1 (1.1)
Depression 1 (2.0) 0 (0.0) 1 (1.1)
Fatigue 5 (10.0) 4 (11.8) 10 (11.4)
Multiple gastrointestinal symptoms 0 (0.0) 1 (2.9) 1 (1.1)
Poor sleep quality 2 (4.0) 0 (0.0) 2 (2.3)
Pruritus/itch 19 (38.0) 8 (23.5) 29 (33.0)
Sleep disturbance 0 (0.0) 1 (2.9) 1 (1.1)
Sleepiness/daytime somnolence 1 (2.0) 0 (0.0) 1 (1.1)
Weakness 1 (2.0) 0 (0.0) 1 (1.1)
Treatment AEs/side effects
Gastrointestinal AEs 2 (4.0) 4 (11.8) 6 (6.8)
Physical AEs 1 (2.0) 4 (11.8) 5 (5.7)
Other
Health perception 0 (0.0) 2 (5.9) 2 (2.3)